Adlai Nortye appoints Christopher Liu as head of investor relations and public relations
Adlai Nortye Group Ltd said it appointed Christopher Liu, Pharmd, as head of investor relations and public relations, effective Sept 30.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. NASDAQ:ANL (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the appointment of Christopher Liu, PharmD…
Adlai Nortye appoints Christopher Liu as head of investor relations and PR
Adlai Nortye appointed Christopher Liu as head of investor relations and public relations. Liu previously was a managing director of equity research at Lucid Capital Markets and holds a PharmD from Rutgers University.
Adlai Nortye appoints Christopher Liu as Head of Investor Relations and PR
Adlai Nortye (ANL) appointed Christopher Liu, PharmD, as Head of Investor Relations and Public Relations.